VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Wuliangye Yibin Co., Ltd. vs Abbott Laboratories
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Wuliangye Yibin Co., Ltd.
000858 · Shenzhen Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Wuliangye Yibin Co., Ltd.'s moat claims, evidence, and risks.
View 000858 analysisAbbott Laboratories
ABT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.
View ABT analysisComparison highlights
- Moat score gap: Wuliangye Yibin Co., Ltd. leads (80 / 100 vs 64 / 100 for Abbott Laboratories).
- Segment focus: Wuliangye Yibin Co., Ltd. has 3 segments (76.1% in Wuliangye-branded Baijiu products); Abbott Laboratories has 7 segments (26.7% in Cardiovascular & Electrophysiology Devices).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Wuliangye Yibin Co., Ltd. has 5 moat types across 3 domains; Abbott Laboratories has 10 across 3.
Primary market context
Wuliangye Yibin Co., Ltd.
Wuliangye-branded Baijiu products
China baijiu market (sales revenue; producers above designated size)
China
Consumers (premium gifting/banqueting; affluent households)
Branded spirits producer and marketer
76.1%
Abbott Laboratories
Cardiovascular & Electrophysiology Devices
Cardiovascular, electrophysiology, rhythm management, structural heart and heart failure devices
Global
Hospitals, ambulatory surgery centers, cardiologists/electrophysiologists
Implantable device manufacturer
26.7%
Side-by-side metrics
Moat coverage
Shared moat types
Wuliangye Yibin Co., Ltd. strengths
Abbott Laboratories strengths
Segment mix
Wuliangye Yibin Co., Ltd. segments
Full profile >Wuliangye-branded Baijiu products
Oligopoly
Other liquor products (Wuliang NongXiang and other series)
Competitive
Non-liquor products (other)
Competitive
Abbott Laboratories segments
Full profile >Established Pharmaceutical Products
Competitive
Diagnostic Products
Oligopoly
Pediatric Nutrition
Oligopoly
Adult Nutrition
Oligopoly
Diabetes Care (CGM & glucose monitoring)
Duopoly
Cardiovascular & Electrophysiology Devices
Oligopoly
Neuromodulation Devices
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.